Log in or Sign up for Free to view tailored content for your specialty!
Emerging Diseases News
New-onset hypertension more common after COVID-19 than after influenza
The incidence of new-onset persistent hypertension is greater in patients with COVID-19 than in those with influenza, researchers reported in Hypertension.
Moderna, Pfizer say updated COVID-19 vaccines protect against EG.5
Moderna this week said preliminary clinical trial data confirmed that its updated COVID-19 vaccine provides a “significant boost” in neutralizing antibodies against emerging SARS-CoV-2 viruses and is expected to effectively target them.
Log in or Sign up for Free to view tailored content for your specialty!
FDA extends approval deadline for Valneva’s chikungunya vaccine by 3 months
The FDA extended the review period for Valneva’s chikungunya vaccine candidate by 3 months while the design of a phase 4 study is finalized.
Study of health workers links nose-picking to SARS-CoV-2 infection
Health care workers who pick their nose were around three times more likely to become infected with SARS-CoV-2 than those who did not, a small study conducted at two hospitals in the Netherlands found.
CMV resistance to maribavir rare at baseline but may emerge
Among transplant recipients treated for cytomegalovirus, resistance to maribavir was less common than resistance to investigator-assigned standard therapy, at baseline and post-treatment, researchers reported.
Clinicians should consider masking during elevated respiratory viral activity, experts say
Experts said clinicians should consider masking during periods of elevated respiratory viral activity after a study linked pandemic prevention measures to decreases in nosocomial COVID-19 and other respiratory viruses.
EG.5 emerges as dominant variant amid summer wave of COVID-19
The EG.5 omicron subvariant has emerged as the predominant SARS-CoV-2 virus during a summer wave of COVID-19 in the Unted States, accounting for 17.3% of cases, according to CDC tracking.
Prevalence of long COVID decreases but many report persistent symptoms
The prevalence of long COVID has declined in the United States among the general population and people with a previously documented case of COVID-19, although many adults still report persistent symptoms, a pair of studies found.
Heart, other organs show mitochondrial damage after COVID-19 despite recovery of lungs
Following SARS-CoV-2 infection, mitochondrial function remained impaired in the heart, liver and kidneys, despite observed recovery in the lungs, according to a human autopsy and animal tissue study.
Study: SARS-CoV-2 attack rate was low in schools — even lower with masks, vaccines
A study of SARS-CoV-2 transmission in 10 Massachusetts school districts found that the secondary attack rate of SARS-CoV-2 among school contacts was low — between 2% and 3% — and that masking reduced the odds of transmission by almost 90%.